Pull back the curtain on emerging CAA 2026 requirements and the benefits transparency rules reshaping employer health plans.
New expectations around rebate pass through, broaderdrug level and aggregate reporting, and shifts in PBM compensation are redefining how plans are structured, evaluated, and managed. At the same time, proposed ERISA 408(b)(2) updates will require deeper visibility into direct and indirect compensation, helping fiduciaries better assess value and reduce opaque pricing. All of this is unfolding alongside rapid changes in AI technology and data use, adding both complexity and opportunity to compliance efforts.
Join ERISA attorneys Dan Kuperstein of Corporate Synergies, and Tom Clark of The Wagner Law Group, for a clear, practical look at what these changes mean and how to respond. Walk away with actionable insights to strengthen compliance, reduce risk, and bring greater clarity to your benefits strategy.
